BioHarvest Sciences Inc. Common Stock Cash Flow Conversion Efficiency
BioHarvest Sciences Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) has a cash flow conversion efficiency ratio of -0.140x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.77 Million) by net assets ($19.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of BioHarvest Sciences Inc. Common Stock (2015–2025)
Cash flow conversion efficiency of BioHarvest Sciences Inc. Common Stock from 2015 to 2025. This chart illustrates how BioHarvest Sciences Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BioHarvest Sciences Inc. Common Stock (BHST) share price today for real-time trading data and today's change.
BioHarvest Sciences Inc. Common Stock Cash Flow Conversion Ratio Explained
BioHarvest Sciences Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
BioHarvest Sciences Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioHarvest Sciences Inc. Common Stock ranked by their cash flow conversion efficiency. Also see BioHarvest Sciences Inc. Common Stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Senheng New Retail Bhd
KLSE:5305
|
0.046x |
|
Eurospan Holdings Bhd
KLSE:7094
|
0.002x |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
0.000x |
|
Zenith Energy Ltd
OL:ZENA
|
-0.156x |
|
Dynamic Precision Industry
TWO:8928
|
0.354x |
|
INFAC Corporation
KO:023810
|
0.157x |
|
Gol Linhas Aéreas Inteligentes S.A
NYSE:GOLLQ
|
-0.024x |
|
SK Discovery Co Ltd
KO:006125
|
0.001x |
Annual Cash Flow Conversion Efficiency for BioHarvest Sciences Inc. Common Stock (2015–2025)
The table below shows the annual cash flow conversion efficiency of BioHarvest Sciences Inc. Common Stock from 2015 to 2025. Review cash generation quality of BioHarvest Sciences Inc. Common Stock to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $25.45 Million | $-7.23 Million | -0.284x | +94.35% |
| 2024-12-31 | $1.33 Million | $-6.68 Million | -5.026x | -975.91% |
| 2023-12-31 | $-14.85 Million | $-8.52 Million | 0.574x | -63.19% |
| 2022-12-31 | $-5.93 Million | $-9.24 Million | 1.559x | +165.50% |
| 2021-12-31 | $2.85 Million | $-6.79 Million | -2.380x | -240.94% |
| 2020-12-31 | $-2.29 Million | $-3.88 Million | 1.688x | +1810.94% |
| 2019-12-31 | $-26.97 Million | $-2.38 Million | 0.088x | +2521.42% |
| 2017-12-31 | $274.05K | $-1.00K | -0.004x | -100.29% |
| 2016-12-31 | $-59.57K | $-74.60K | 1.252x | +115.88% |
| 2015-12-31 | $16.09K | $-126.82K | -7.884x | -- |
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and w… Read more